TrendsOnFire / Transformation / Philips
Corporate Transformation Intelligence · Netherlands 2025

Philips Transformation Intelligence — Netherlands Focus

How Europe's most complex corporate reinvention is reshaping healthcare, consumer, and supply chain operations — and what it means for talent and capability demand in the Netherlands through 2026–2027.

€17B revenue · 80,000+ employees globally 9+ concurrent transformation programmes in NL Updated March 2026
NL Headcount
~14k
Post-restructuring (from ~18k in 2021)
Recall Provisions
€4.4B+
Respironics total cost 2021–2024
Roles Reduced
16k+
Global, across 3 restructuring waves
Revenue (2024)
€17B
Health technology focus post-divestiture

One of the most complex corporate reinventions in Dutch industrial history — driven by a product safety crisis, a strategic pivot to pure-play health technology, and simultaneous restructuring across 80,000+ employees globally. The Netherlands is the centre of gravity: R&D, global functions, supply chain, commercial operations, and ecommerce are all NL-based. Demand for experienced leadership in transformation, ecommerce, commercial strategy, programme management, and supply chain will remain elevated through 2026–2027.

Netherlands Spotlight
Key Facts — Philips in the Netherlands 2025
NL Headcount
~14,000 (post-restructuring)
NL-Based Global Functions
Supply Chain, R&D, Regulatory, Procurement, Finance, Ecommerce
Senior Leadership Demand
High — 9+ simultaneous programmes require experienced external directors
Transformation Scope
9+ simultaneous programmes across quality, digital, ecommerce, supply chain, strategy
Key NL Locations
Amsterdam
Group HQ, commercial leadership, EMEA & ecommerce functions
Eindhoven
Global R&D centre, imaging & AI development, NPI
Best
Image guided therapy global commercial HQ
Drachten
Personal Health manufacturing, Philishave heritage site
Active Transformation Programmes — Netherlands
Transformation Capability Demand — 2025–2027 Outlook
Programme & Change Management
Very High
Simultaneous restructuring across all divisions; internal capacity consumed by BAU recovery
Quality & Compliance Transformation
Very High
FDA consent decree €1B+ obligation; EU MDR compliance; QMS rebuild across supply chain
E-Commerce & DTC Strategy
High
Personal Health DTC expansion; digital shelf & fulfilment leadership; consumer channel strategy
Commercial Strategy & Portfolio
High
Managed services pivot; hospital partnership models; go-to-market redesign across EMEA
Supply Chain Transformation
High
Post-recall resilience redesign; nearshoring; supplier rationalisation and dual-source qualification
Digital Transformation
High
AI-embedded device integration; subscription platform build; hospital data interoperability
Customer Service Transformation
High
Reactive to proactive model shift; outcome-based SLAs; trust recovery post-recall
NPI & Launch Excellence
High
Accelerated launch cadence across imaging and interventional; NPI governance overhaul in Eindhoven
Operating Model Redesign
Medium–High
New divisional structure embedding; shared services optimisation; commercial model redesign
Operational Excellence & CI
Medium–High
Lean deployment across manufacturing and service operations; efficiency recovery post-recall
The Transformation Backdrop — 2021 to 2025
2021
2021 — The Crisis
Respironics CPAP Recall Announced
Philips recalls 5.5 million sleep and respiratory care devices due to foam degradation risks. The defining event of the 2021–2025 period — triggering regulatory action, litigation, and billions in provisions.
Oct 22
October 2022 — Leadership Change
Roy Jakobs Appointed CEO
Frans van Houten steps down. Jakobs takes the helm with a clear mandate: resolve the recall, stabilise the balance sheet, sharpen strategic focus. Major restructuring announced within weeks.
Nov 22
November 2022 — Restructuring
"Philips Fit" — 10,000 Role Reductions
10,000 roles cut globally across commercial, operational, and support functions. Netherlands HQ functions, shared services, and business unit roles all affected.
2023
2023 — Second Wave + Regulatory
6,000 Further Reductions + FDA Consent Decree
A further 6,000 roles removed. US FDA issues a consent decree requiring a mandatory quality management system overhaul across manufacturing, supply chain, and post-market surveillance. Compliance investment exceeds €1B.
2023–24
2023–2024 — Portfolio Simplification
Divest, Refocus, Rebuild
Portfolio converges on three pillars: Diagnostic Imaging, Image Guided Therapy, and Personal Health. Go-to-market shifts from product-push to managed services and hospital partnerships. DTC and ecommerce investment accelerated for Personal Health.
2025
2025 — Stabilisation
Return to Profitability, New Operating Model Embedding
Philips returns to operating profit. New divisional structure fully embedded. Quality systems redesigned. Transformation is far from over — digital platform deployment, ecommerce expansion, NPI acceleration, and commercial strategy evolution are all live programmes.
Business Division Transformation Map
Image Guided Therapy NL: High

Interventional & Image Guided Therapy

Focus

NPI acceleration, shift to solutions-as-a-service, hospital partnership deepening. Global commercial HQ in Best (Netherlands).

Capability Gaps
  • NPI programme management and launch excellence
  • Solutions architecture and service design
  • Change management for sales model transition
Diagnostic Imaging NL: High

Diagnostic Imaging & Informatics

Focus

Cloud migration, AI integration into radiology workflows, subscription revenue shift. Core R&D in Eindhoven.

Capability Gaps
  • Digital transformation and platform migration leadership
  • Product-to-subscription operating model change
  • Clinical training and application specialist programmes
Connected Care NL: Medium

Connected Care & Patient Monitoring

Focus

Quality overhaul post-Respironics, supply chain redesign, customer trust recovery. FDA consent decree is the dominant programme.

Capability Gaps
  • QMS transformation and compliance programme management
  • Supply chain resilience and dual-source redesign
  • Customer trust recovery programme leadership
Personal Health NL: High

Personal Health — Consumer Division

Focus

DTC and ecommerce acceleration, subscription model (Sonicare, Philishave), competitive repositioning against Asian challengers. Amsterdam and Eindhoven operations.

Capability Gaps
  • E-commerce strategy and DTC operating model leadership
  • Consumer channel and digital shelf management
  • Subscription model operations and new service development
  • Supply chain localisation and resilience
Enterprise Informatics NL: High

Enterprise Informatics

Focus

Commercial operations redesign for the global Informatics portfolio; shift to predictable, scalable revenue model; CRM, CPQ, and forecasting infrastructure build across markets.

Capability Gaps
  • Commercial operations leadership and go-to-market model design
  • Forecasting framework and revenue governance
  • Sales productivity and commercial process standardisation
Market Signal — Transformation & Commercial Leadership Demand

Philips represents a once-in-a-decade transformation in the Netherlands — a €17B organisation simultaneously rebuilding its operating model, quality systems, supply chain, ecommerce channels, commercial strategy, and digital infrastructure. The demand for experienced leadership across transformation, ecommerce, strategy, programme management, and operational excellence is significant and will remain elevated through 2026–2027.

Available for Permanent & Interim Roles

I'm an experienced transformation and commercial operations executive available for permanent and interim Director-level roles in transformation, ecommerce, omni-channel, supply chain, operations, programme management, and change leadership — across the Netherlands and Europe.

Open to a conversation →